Poland–Italy Aortic Bridge Registry: PERCUTEK Tycheseal for Abdominal Aortic Aneurysm
A Pragmatic, Observational, Multicenter Registry on the Implantation of the Tri Modular PERCUTEK Tycheseal™ Endograft System for the Treatment of Abdominal Aortic Aneurysm (AAA)
This registry will see how well the PERCUTEK Tycheseal stent-graft works and how safe it is for adults having endovascular repair of abdominal aortic aneurysms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | American Heart of Poland Academic / other |
| Locations | 26 sites (Castel Volturno and 25 other locations) |
| Trial ID | NCT07476196 on ClinicalTrials.gov |
What this trial studies
This is a pragmatic, observational multicenter registry collecting patient-level clinical, anatomical, procedural, and follow-up data from participating centers in Italy and Poland on use of the PERCUTEK Tycheseal stent-graft. Sites will record information on standardized paper case report forms and follow data entry timelines and quality-control checks. The projected enrollment is 120–200 patients over an approximately 18-month inclusion period, with inclusion guided by the device instructions-for-use (anatomic and clinical criteria). The registry focuses on technical success, device-related safety events, and mid-term clinical and imaging outcomes in routine practice.
Who should consider this trial
Good fit: Adults (age >18) with abdominal aortic aneurysm who meet the device anatomic criteria (for example adequate neck length and diameters per IFU), can consent, and can complete follow-up are ideal candidates.
Not a fit: Patients with anatomically unsuitable aneurysms, ruptured aneurysm, life expectancy under one year, contraindications to device materials or required therapies, recent stroke/MI, prior aortoiliac surgery or EVAR, or other exclusion criteria are unlikely to benefit from inclusion.
Why it matters
Potential benefit: If successful, the registry could provide real-world evidence on the safety and mid-term effectiveness of the PERCUTEK Tycheseal device to help clinicians select patients and refine procedural technique.
How similar studies have performed: Endovascular stent-grafts are an established treatment for AAA and multiple registries and trials of comparable devices have shown favorable outcomes, but real-world data specific to the PERCUTEK Tycheseal system are currently limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Anatomical Inclusion Criteria (as per IFU): * Morphologically suitable aneurysm * Neck length ≥ 10 mm * Neck diameter suitable for 20-36 mm body (considering 10-20% of oversizing) * Neck angle: infrarenal ≤ 75° * Distal seal zone ≥ 10 mm * Iliac arteries 8-20 mm diameter Patient Inclusion Criteria: * Age \>18 years * Signed informed consent * Pregnancy test for premenopausal women Exclusion Criteria: * Anatomical unsuitability * Subject has a life expectancy \< 1 year * Circumferential thrombus in neck * Ruptured aneurysm * Renal arteries from aneurysm sac * Dominant IMA with obstructed visceral vessels * Internal iliac artery aneurysms (unless pre-treated) * Subject has a known contraindication dual antiplatelets therapy or contrast media, * Selected patients with chronic kidney failure (CKF) can undergo EVAR using standard contrast or CO2 as contrast agent. * Previous aortoiliac surgery or EVAR * Recent stroke/MI (\< 3 months) * Allergy to device materials
Where this trial is running
Castel Volturno and 25 other locations
- Clinica Pineta Grande — Castel Volturno, Italy (Not_yet_recruiting)
- Centro Cuore Morgagni — Catania, Italy (Not_yet_recruiting)
- IRCCS Neuromed - Istituto Neurologico Mediterraneo — Pozzilli, Italy (Not_yet_recruiting)
- Arcispedale Santa Maria Nuova — Reggio Emilia, Italy (Not_yet_recruiting)
- Policlinico San Donato — San Donato Milanese, Italy (Not_yet_recruiting)
- Uniwersytecki Szpital Kliniczny w Białymstoku — Bialystok, Poland (Recruiting)
- Szpital Wojewódzki w Bielsku-Białej — Bielsko-Biala, Poland (Recruiting)
- Wojewódzki Szpital Specjalistyczny nr 4 — Bytom, Poland (Recruiting)
- Małopolska Cardiovascular Center, Polish-American Heart Clinic in Chrzanów — Chrzanów, Poland (Recruiting)
- 118 Szpital Wojskowy z Przychodnią SPZOZ — Ełk, Poland (Recruiting)
- Szpital im. Św. Wincentego a Paulo — Gdynia, Poland (Recruiting)
- Wojewódzki Szpital Zespolony — Kielce, Poland (Recruiting)
- Bonifraterskie Centrum Medyczne — Krakow, Poland (Recruiting)
- Krakowski Szpital Specjalistyczny im. JPII — Krakow, Poland (Recruiting)
- Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego — Lublin, Poland (Recruiting)
- Uniwersytecki Szpital Kliniczny Nr 4 — Lublin, Poland (Recruiting)
- Wojewódzki Szpital Specjalistyczny w Lublinie — Lublin, Poland (Recruiting)
- Uniwersytecki Szpital Kliniczny w Opolu — Opole, Poland (Recruiting)
- Uniwersytecki Szpital Kliniczny w Poznaniu — Poznan, Poland (Recruiting)
- Wojewódzki Szpital im. Św. Ojca Pio — Przemyśl, Poland (Recruiting)
- Uniwersytecki Szpital Kliniczny Nr 2 PUM — Szczecin, Poland (Recruiting)
- Mazowiecki Szpital Bródnowski — Warsaw, Poland (Recruiting)
- Narodowy Instytut Kardiologii — Warsaw, Poland (Recruiting)
- Uniwersyteckie Centrum Kliniczne WUM — Warsaw, Poland (Recruiting)
- Wodzisławskie Centrum Medyczne — Wodzisław Śląski, Poland (Recruiting)
- Szpital Uniwersytecki im. Karola Marcinkowskiego — Zielona Góra, Poland (Recruiting)
Study contacts
- Principal investigator: Przemysław Nowakowski, MD,PhD, Prof — American Heart of Poland
- Study coordinator: Przemysław Nowakowski, MD, PhD, Prof
- Email: nowakowski.mcsn@gmail.com
- Phone: (+48) 32 758 69 01
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.